News &
Events
IP NEWS
Cybersecurity: What You Need to Know and Do to Avoid a Breach
We are fast approaching the second anniversary of the enactment of the European Union General Data Protection Regulation (GDPR), yet businesses are still dragging their [...]
Allergan Inks $51M Deal To End Direct Buyers’ Restasis Suit
Allergan has struck a $51.2 million deal with Restasis buyers to end allegations that the pharma giant fought to keep a generic version of its [...]
Buchanan Ingersoll & Rooney Seeks Electrical Patent Associate
Buchanan Ingersoll & Rooney has an immediate opening for an Electrical Patent Associate with at least 3-5 years of experience in Blockchain and distributed ledger [...]
EPO exams: to change or not to change?
With the qualification process for UK attorneys being reviewed, lawyers in France, Germany and the UK ask whether the European system also needs an overhaul [...]
You Own It, Now What Are You Going to Do with It? – Why Trade Secrets Are Treated Like Property: Part 2
In last month’s post, Part 1 of this series, we considered the view of European academics that trade secrets are not “intellectual property” because they [...]
Fed. Circ. Skeptical ID Theft Patents Wrongly Axed Under Alice
Mantissa Corp. faced a steep climb at the Federal Circuit Tuesday in trying to persuade the court to undo a district court decision invalidating two [...]
Gov’t Bid To Undo Arthrex-Based Remand Flops At Fed. Circ.
The full Federal Circuit has left in place a panel decision vacating the Patent Trial and Appeal Board’s invalidation of a technology licensing company’s patent, [...]
Chevron, Sariel Await Jury’s Decision In $3M Trademark Case
No verdict was returned Tuesday in the trademark infringement lawsuit Chevron brought against Sariel Petroleum LLC, accusing the smaller company of pretending it was affiliated [...]
Vereins May Come Into Crosshairs With $32M Dentons Verdict
A recent $32 million verdict against Dentons could spur law firms and regulators to rethink whether a BigLaw behemoth organized as a verein should be [...]
Fed. Circ. Won’t Rehear Partial Ax Of Horizon Arthritis Drug IP
A divided Federal Circuit on Tuesday declined to revisit a ruling that struck down parts of Horizon’s patents for its arthritis drug Pennsaid, drawing a [...]
Texas PI Firm Says Referral Website Violates Trademarks
A Dallas-area personal injury law firm has accused an attorney referral website of manipulating search engine results to steal potential clients who searched for the [...]
Atty Sued By Wyndham Agrees To Quit Timeshare Exit Biz
Wyndham Vacation Ownership Inc. and an attorney accused of running a bogus timeshare exit scheme have jointly asked a Florida federal judge to approve a [...]
Fed. Circ. Upholds Sony’s PTAB Win On Imaging Patent
The Patent Trial and Appeal Board rightly found that Collabo Innovations Inc. waived the right to fight a certain claim construction before invalidating the company's [...]
Google Weighs In On Whether Servers Are ‘Agents’ For Venue
Google has hit back at arguments that its servers qualify as agents in the Eastern District of Texas for patent venue purposes, saying that the [...]
Patentees Should Consider Alternatives To IPR Amendments
Although data indicates that inter partes review amendment proceedings are the go-to option to save challenged patents, their relatively low success rates should prompt patent [...]
Nike Calls Trademark Ad Ban ‘Restraint On Speech’
Nike Inc. is urging a federal appeals court to undo a trademark ruling that forced the company to halt an ad campaign centered on the [...]
Four Judges Dissent from CAFC Denial of Rehearing in Generic Osteoarthritis Drug Case
The U.S. Court of Appeals for the Federal Circuit (CAFC) today denied HZNP Medicines LLC’s (Horizon’s) request for rehearing in HZNP Medicines LLC v. Actavis [...]
Drug Approval Law Will Likely Deter Pharma Delay Tactics
The Creating and Restoring Equal Access to Equivalent Samples Act that Congress recently enacted should effectively discourage pharmaceutical companies from delaying lower-cost generic and biosimilar [...]
Phanatic Creators Slam Team’s Mascot Redesign Amid IP Suit
After the Philadelphia Phillies unveiled a slightly redesigned version of the Phillie Phanatic over the weekend, the famed mascot’s creators slammed the team Tuesday for [...]
Discrimination Cases Are Too Complex For AI Fee Prediction
A recent Law360 guest article criticizing the New Jersey Supreme Court’s ruling in Balducci v. Cige overlooks the intricate nature of discrimination cases, which renders [...]
Insurer Needn’t Defend Conflict Training Firm In TM Fight
A Wisconsin appeals court on Tuesday affirmed that Cincinnati Specialty Underwriters Insurance Co. doesn’t have to cover costs for conflict management training firm Vistelar LLC [...]
Fresenius Loses ‘Unduly Speculative’ Generic Drug Row
A New Jersey federal judge Tuesday tossed Fresenius Kabi’s antitrust suit against Par Pharmaceuticals, which alleged that the drug ingredient maker blocked it from marketing [...]
PNY Urges Full 3rd Circ. To Rehear $2.2M IP Royalty Dispute
Flash memory maker PNY Technologies said Monday the full Third Circuit should rehear its appeal after a panel refused to “second-guess” a New Jersey arbitrator’s [...]
Amici Back Booking.com in Supreme Court Case Against USPTO
As argument nears in the Supreme Court battle between Booking.com and the United States Patent and Trademark Office (USPTO), 12 parties have now filed amicus [...]
